Medicine and Dentistry

1. Patient 100%
2. Neoadjuvant Chemotherapy 88%
3. Neoplasm 87%
4. Adenocarcinoma 56%
5. Analysis 53%
6. Surgical Margin 52%
7. Esophageal Adenocarcinoma 52%
8. Diagnosis 50%
9. Histopathology 47%
10. Hazard Ratio 44%
11. Positron Emission Tomography-Computed Tomography 40%
12. Chemotherapy 36%
13. Esophageal Cancer 34%
14. Recurrent Disease 32%
15. Therapeutic Procedure 30%
16. Lymph Node 30%
17. Stomach Adenocarcinoma 30%
18. Adjuvant Therapy 26%
19. Esophagus 25%
20. Esophagectomy 25%
21. Isotopes of Calcium 23%
22. Human Immunodeficiency Virus Infection 23%
23. Intracellular Calcium 23%
24. Immunohistochemistry 23%
25. Cardiovascular System 23%
26. Cardia 23%
27. Human Immunodeficiency Virus 1 23%
28. Local Excision 23%
29. Adult T-Cell Leukemia/Lymphoma 23%
30. Glucose 23%
31. Chemotherapy Regimens 23%
32. Hypercalcaemia 23%
33. Medical Research 23%
34. PET-MRI 23%
35. Fluorodeoxyglucose F 18 23%
36. Experience 23%
37. Infection 23%
38. Adjuvant Chemoradiotherapy 14%
39. Mixed Tumor 13%
40. Proportional Hazards Model 12%
41. Primary Tumor 12%
42. Cardiac Dysrhythmia 11%
43. Hematologic Malignancy 11%
44. Cancer Staging 9%
45. Cohort Analysis 9%
46. Hospital 7%
47. Neoadjuvant Therapy 7%
48. Malignant Neoplasm 7%
49. Adverse Event 7%
50. Postoperative Complication 7%